苍耳子鼻炎滴丸联合头孢呋辛治疗急性鼻窦炎患者的临床疗效

doi:10.3969/j.issn.1671-7171.2026.01.031

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1159 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the clinical efficacy of Xanthium Rhinitis Dripping Pills combined with cefuroxime in the treatment of patients with acute sinusitis. 【Methods】 A total of 101 patients with acute sinusitis admitted to our hospital from March 2023 to March 2025 were selected and divided into a control group(n=51, treated with cefuroxime plus placebo with identical appearance) and an observation group(n=50, treated with cefuroxime plus Xanthium Rhinitis Dripping Pills) using a computer-generated random sequence(completed by an independent statistician). During the study period, 3 cases in the control group(2 lost to follow-up, 1 withdrew voluntarily) and 2 cases in the observation group(lost to follow-up) dropped out, and finally 96 cases completed all follow-up visits(48 cases in each group). The clinical efficacy, inflammatory indicators, nasal endoscopy scores(Lund-Kennedy scores), clinical symptoms and incidence of adverse reactions were compared between the two groups. 【Results】 The total effective rate of the observation group was higher than that of the control group(P<0.05). After treatment, the serum levels of hypersensitive C-reactive protein(hs-CRP) and procalcitonin(PCT) in the observation group were lower than those in the control group(P<0.05), and the Lund-Kennedy scores and the scores of all dimensions of the Sinonasal Outcome Test-20(SNOT-20) in the observation group were lower than those in the control group(P<0.05). There was no statistically significant difference in the total incidence of adverse reactions between the two groups(P>0.05).【Conclusion】 Xanthium Rhinitis Dripping Pills combined with cefuroxime can improve the clinical efficacy of patients with acute sinusitis, alleviate the inflammatory response, and has good safety, which is worthy of clinical promotion and application.

Key words： Sinusitis Acute Disease Dripping Pills Cefuroxime Treatment Outcome

Received: 11 August 2025

PACS:

R765.41

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SHAO Hong

Cite this article:

SHAO Hong. Clinical Efficacy of Xanthium Rhinitis Dripping Pills Combined with Cefuroxime in the Treatment of Patients with Acute Sinusitis[J]. JOURNAL OF CLINICAL RESEARCH, 2026, 43(1): 110-113.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2026.01.031 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2026/V43/I1/110

[1] 钱志君,蔡燕文,邓佩仪,等. 辛夷散联合氦氖激光治疗鼻-鼻窦炎疗效观察[J].辽宁中医杂志,2025,52(3):88-91.
[2] 黎仙,李景云,张媛. HLA多态性与过敏性鼻炎、慢性鼻窦炎和哮喘:机制与研究进展[J].中国耳鼻咽喉头颈外科,2025,32(1):65-68.
[3] 杨明,周玥. 头孢呋辛与阿奇霉素治疗慢性鼻窦炎疗效比较[J].现代中西医结合杂志,2015(21):2342-2343.
[4] 徐志远,秦永,陈凤义. 苍耳子鼻炎滴丸联合氯雷他定治疗过敏性鼻炎临床观察[J].中国药业,2020,29(2):70-72.
[5] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J].中华耳鼻咽喉头颈外科杂志,2019,54(2):81-100.
[6] 国家中医药管理局.中药新药临床研究指导原则[S]. 北京:中国医药科技出版社,2002.
[7] 边赛男,庞冲,张冰,等. 改良Lund-Kennedy鼻内镜评分系统在慢性鼻炎评估中的意义[J].中华临床免疫和变态反应杂志,2021,15(3):286-291.
[8] 左可军,方积乾,PICCIRILLO J F,等. 鼻腔鼻窦结局测试-20(SNOT-20)量表中文版的研制[J].中华耳鼻咽喉头颈外科杂志,2008,43(10):751-756.
[9] 徐英,高萌,宋咏霞,等. 清热解毒方联合莫西沙星治疗急性鼻窦炎临床疗效及对血清炎性因子hs-CRP、IL-6、TNF-α影响[J].中华中医药学刊,2024,42(9):232-235.
[10] 郝亚楠,黄卫. 散风通窍滴丸治疗急性鼻窦炎的疗效[J].贵州医科大学学报,2022,47(6):699-703.
[11] 张庆泉,张华. 苍耳子鼻炎滴丸联合爱赛平鼻喷剂治疗季节性变应性鼻炎的临床观察[J].中国中西医结合耳鼻咽喉科杂志,2016,24(2):101-103.
[12] 丁振涛,韩荣荣,余彦彤,等. 基于HMGB1炎症通路的苍耳子砂炒减毒机制研究[J].湖南中医药大学学报,2024,44(7):1175-1180.
[13] 李树华,邓伟,蒋振华,等. 苍耳子鼻炎滴丸对难治性变应性鼻炎的疗效和功能恢复的影响[J].中国中西医结合耳鼻咽喉科杂志,2024,32(1):24-28.
[14] 杨祁,李泽卿,朱春晖,等. 辛夷脂素对大鼠变应性鼻炎的治疗作用及相关炎性因子的影响[J].中国中西医结合耳鼻咽喉科杂志,2025,33(1):6-10.
[15] 张竞飞,俞鹏飞,安月鹏,等. 吉雷开窍汤联合西药治疗对胆腑郁热型慢性鼻窦炎患儿鼻腔菌群和鼻腔功能的影响[J].陕西中医,2025,46(4):472-475.